(b)(4).It is indicated that the device is not returning for evaluation; therefore, a failure analysis of the complaint device could not be completed.The reported use after expiration date appears to be user related.A review of the lot history record revealed no non-conformances that would have contributed to the reported event.A query of the electronic complaint handling database revealed no other incidents for use after expiration reported from this lot.It should be noted that the supera instruction for use states: use this device prior to the use by (expiration) date as specified on the device package label.Based on the information reviewed, there is no indication of a product quality issue with respect to manufacture, design or labeling.
|
It was reported that on (b)(6) 2015, the patient underwent a peripheral stenting procedure with placement of a supera stent in the right popliteal artery.The supera stent was deployed without difficulty; however, after deployment, it was noted that the stent had expired on (b)(6) 2015.There was no adverse patient effect.No additional information was provided.
|